Posts by Sandra Ansanay-Alex
WEF – Technology Pioneer
Apply before 31 January 2026 for the Technology Pioneer Contest organised by the World Economic Forum The World Economic Forum’s Technology Pioneers community is composed of early-stage start-ups from around the world who are developing and deploying new technologies and innovations. Each year the Forum selects 100 companies to work with society’s foremost political, business and cultural…
Read MoreSwiss HLG Basel Netwoking Event with Roche
The Swiss HLG Basel Netwoking Event with Roche is taking place on 27 November 2025 in Basel.
Read MoreORION: A smart microfactory to accelerate personalized cancer treatments
The watchmaking microfactory developed by Haute Ecole Arc Ingénierie has inspired ORION, a new research project bringing together 24 partners around personalized cancer treatments. ORION is one of four projects selected by the Swiss Federal Innovation Agency Innosuisse as part of its flagship initiative, “Artificial Intelligence in the Life Sciences, from a Human Health Perspective.”With…
Read MoreSymposium Medecine Centrée Patient
This symposium, organised by Agora Care, is taking place on 26 November 2026 at Campus Biotech Geneva. Switzerland is seeing a proliferation of healthcare network initiatives aimed at optimising patient pathways while controlling healthcare costs. This opens up new challenges in professional practices. Among these, the positioning of the patient, both within and outside their…
Read MoreBiotech for Good 2025
Biotech for Good is taking place on Thursday 27 November 2025, at L’IceBergues in Geneva.
Read MoreProtonica Gets a CHF 400,000 Innosuisse Grant
The EPFL spin-off announces a new Innosuisse grant of approximately CHF 400,000, awarded with strong support from EPFL and CSEM. Protonica is on a mission to transform cancer care by making proton therapy more precise, effective, and accessible. Unlike conventional radiotherapy, proton therapy can target tumors with high accuracy, limiting damage to healthy tissue and…
Read MoreOculis Raises $110 Million to Accelerate its Development
The Swiss-Icelandic ophthalmology company Oculis, based in Zug with its operational headquarters in Lausanne, has completed an oversubscribed capital increase of $110 million. This is its second fundraising round exceeding $100 million in less than a year, following the one in February. Net proceeds from the financing will be used to advance and accelerate the…
Read MoreForum Santé – Le Temps
On 25 November 2025, Le Temps and Heidi.news will host the eighth edition of the Health Forum at the Palais de Beaulieu in Lausanne. The healthcare system is misnamed. Focused primarily on treatment, it repairs but often intervenes too late, at a time when the population is ageing and chronic diseases are on the rise.The…
Read MoreSwiss Dementia Forum
The Swiss Dementia Forum is taking place on 6-7 November in Bern
Read MoreCHUV and HUG among Europe’s most innovative hospitals
The university hospitals of the Swiss Health Valley confirm their scientific excellence, placing Switzerland among the select group of nations most dynamic in hospital research
Read More